Carregant...
EXTENDED DURATION DUAL ANTIPLATELET THERAPY AND MORTALITY – A SYSTEMATIC REVIEW AND META-ANALYSIS
BACKGROUND: Treatment with the combination of aspirin and a P2Y12 inhibitor is commonly employed in a number of cardiovascular conditions. The overall impact of such treatment on all-cause mortality is unknown. In the Dual Antiplatelet Therapy (DAPT) Study, an international multicenter randomized pl...
Guardat en:
| Publicat a: | Lancet |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386690/ https://ncbi.nlm.nih.gov/pubmed/25467565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(14)62052-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|